SYNGENE.NS Syngene International Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 293096 | 169258 | 57.75% |
| 2026-08-27 | 479502 | 252566 | 52.67% |
| 2026-08-26 | 567950 | 242749 | 42.74% |
| 2026-08-25 | 399141 | 208706 | 52.29% |
| 2026-08-24 | 268563 | 144956 | 53.97% |
| 2026-08-21 | 953583 | 475631 | 49.88% |
| 2026-08-20 | 1883583 | 1173819 | 62.32% |
| 2026-08-19 | 366481 | 167660 | 45.75% |
| 2026-08-18 | 335081 | 203435 | 60.71% |
| 2026-08-17 | 306199 | 200045 | 65.33% |
| 2026-08-14 | 497308 | 295773 | 59.47% |
| 2026-08-13 | 810276 | 448761 | 55.38% |
| 2026-08-12 | 591399 | 378298 | 63.97% |
| 2026-08-11 | 405459 | 218934 | 54.00% |
| 2026-08-10 | 1885130 | 1227435 | 65.11% |
| 2026-08-07 | 2260564 | 1438180 | 63.62% |
| 2026-08-06 | 806023 | 352554 | 43.74% |
| 2026-08-05 | 541762 | 276606 | 51.06% |
| 2026-08-04 | 925377 | 442678 | 47.84% |
| 2026-08-03 | 1674593 | 857211 | 51.19% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers SYNGENE.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 27 Dec 2024 | ANJAN CHAKRABARTI | Employees/Designated Employees | Sell | Market Sale | 6190 | 5265152 | 0.01% | XBRL |
| 23 Dec 2024 | ANJAN CHAKRABARTI | Employees/Designated Employees | Buy | ESOP | 58390 | 50199635 | 0.01% | XBRL |
| 23 Dec 2024 | ANJAN CHAKRABARTI | Employees/Designated Employees | Sell | Market Sale | 27200 | 22944288 | 0.01% | XBRL |
| 11 Dec 2024 | Biocon Limited | Promoters | Sell | Market Sale | 8000000 | 6861440000 | 52.46% | XBRL |
| 28 Nov 2024 | DEEPAK VENKATRAMAN | Employees/Designated Employees | Sell | Market Sale | 600 | 533610 | 0.00% | XBRL |
| 28 Nov 2024 | DEEPAK VENKATRAMAN | Employees/Designated Employees | Sell | Market Sale | 600 | 544290 | 0.00% | XBRL |
| 28 Nov 2024 | Mayank Verma | Employees/Designated Employees | Sell | Market Sale | 1500 | 1369755 | 0.00% | XBRL |
| 18 Nov 2024 | ALOK MEHROTRA | Employees/Designated Employees | Buy | ESOP | 20000 | 17520600 | 0.01% | XBRL |
| 18 Nov 2024 | ALOK MEHROTRA | Employees/Designated Employees | Sell | Market Sale | 8200 | 7037404 | 0.01% | XBRL |
| 11 Nov 2024 | SIBAJI BISWAS | Key Managerial Personnel | Buy | ESOP | 86431 | 76917540 | 0.04% | XBRL |
| 11 Nov 2024 | SIBAJI BISWAS | Key Managerial Personnel | Sell | Market Sale | 35000 | 31977400 | 0.03% | XBRL |
| 05 Sep 2024 | CHETAN PRAKASH TAMHANKA | Employees/Designated Employees | Sell | Market Sale | 2394 | 2091398 | 0.01% | XBRL |
| 04 Sep 2024 | Ajit Manocha | Employees/Designated Employees | Sell | Market Sale | 2587 | 2276560 | 0.00% | XBRL |
| 03 Sep 2024 | Ajit Manocha | Employees/Designated Employees | Sell | Market Sale | 2500 | 2180000 | 0.00% | XBRL |
| 29 Aug 2024 | Ajit Manocha | Employees/Designated Employees | Sell | Market Sale | 5000 | 4225000 | 0.00% | XBRL |
| 28 Aug 2024 | ALOK MEHROTRA | Employees/Designated Employees | Sell | Market Sale | 1000 | 853990 | 0.01% | XBRL |
| 28 Aug 2024 | ALOK MEHROTRA | Employees/Designated Employees | Sell | Market Sale | 500 | 428540 | 0.01% | XBRL |
| 27 Aug 2024 | G KRISHNAN | Employees/Designated Employees | Sell | Market Sale | 5000 | 4234400 | 0.00% | XBRL |
| 27 Aug 2024 | Manoj Gupta | Employees/Designated Employees | Sell | Market Sale | 6400 | 5443200 | 0.00% | XBRL |
| 23 Aug 2024 | CHETAN PRAKASH TAMHANKA | Employees/Designated Employees | Buy | ESOP | 17287 | 14386241 | 0.01% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers SYNGENE.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
Eroding
ROCE Trajectory
Earnings Quality
Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹916.90 Cr. | ₹789.70 Cr. | ₹891.00 Cr. | ₹943.70 Cr. | ₹1,018.00 Cr. | ₹874.50 Cr. | ₹910.60 Cr. | ₹917.10 Cr. | ₹1,036.50 Cr. | ₹736.00 Cr. | RevenueFromOperations |
| Net Profit | ₹188.60 Cr. | ₹75.70 Cr. | ₹106.10 Cr. | ₹131.10 Cr. | ₹183.30 Cr. | ₹86.70 Cr. | ₹67.10 Cr. | ₹15.00 Cr. | ₹147.90 Cr. | ₹-9.00 Cr. | ProfitLossForPeriod |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers SYNGENE.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitLossForPeriod | 3167000000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 402900000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 21428000000.0 |
| CurrentLiabilities | 15523000000.0 |
| EquityAttributableToOwnersOfParent | 48391000000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 94000000.0 |